Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nivolumab melanoma | 1.16 | 0.5 | 9384 | 77 | 18 |
nivolumab | 1.97 | 0.7 | 4560 | 97 | 9 |
melanoma | 0.16 | 0.3 | 5700 | 5 | 8 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nivolumab melanoma | 0.9 | 0.5 | 8970 | 98 |
nivolumab melanoma approval | 0.81 | 0.6 | 7340 | 41 |
nivolumab melanoma fda | 1.82 | 0.3 | 3067 | 38 |
nivolumab melanoma eviq | 0.9 | 1 | 5040 | 43 |
nivolumab melanoma adjuvant | 0.16 | 0.7 | 1102 | 74 |
nivolumab melanoma treatment | 1.58 | 0.3 | 6525 | 30 |
nivolumab melanoma effetti collaterali | 1.52 | 0.7 | 3914 | 27 |
pembrolizumab versus nivolumab for melanoma | 1.86 | 0.7 | 6946 | 13 |
nivolumab and pembrolizumab for melanoma | 1.34 | 0.9 | 5076 | 35 |
relatlimab nivolumab melanoma | 1.91 | 0.6 | 9766 | 33 |
ipilimumab and nivolumab melanoma | 1.88 | 0.9 | 2915 | 11 |
pembrolizumab vs nivolumab melanoma | 1.92 | 0.2 | 6527 | 6 |
nivolumab ipilimumab melanoma | 0.5 | 0.8 | 5898 | 45 |